等待開盤 11-18 09:30:00 美东时间
-0.014
-12.77%
Baird Medical has entered a strategic partnership with ALLIS MED, appointing it as the exclusive distributor for its Microwave Ablation (MWA) products in South Korea. ALLIS MED will manage regulatory certifications and market推广 of the technology, aiming to introduce MWA as an alternative to radiofrequency ablation for thyroid tumor treatment. This marks Baird Medical's latest expansion in Asia, following entries into markets like Argentina, Egypt...
11-12 13:00
Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) shares fell in after-hours trading Thursday after the company announced that its strategic partner, Alpmed, had submitted regulatory applications in the U.S. and European Union for an irreversible electroporation (IRE) system. Baird Medical is a me...
11-06 14:00
Shares of Limbach Holdings, Inc. (NASDAQ:LMB) rose sharply in pre-market trading after the company reported upbeat third-quarter financial results and raised its FY26 sales guidance above estimates. Limbach Holdings reported quarterly earnings of $1.37 per share which beat the analyst consensus esti...
11-04 17:47
Baird Medical highlighted Q3 2026 developments including participation in the H.C. Wainwright Global Investment Conference, a strategic partnership with Alpmed to expand its minimally invasive technology portfolio, new regulatory registrations in Pakistan, and advancements in physician training programs. The company also expanded its MWA technology into Vietnam and Argentina, and engaged with global medical communities at key industry events. Bai...
10-05 12:00
Baird Medical participated in the CIRSE 2026 Annual Congress in Copenhagen, showcasing its Microwave Ablation (MWA) System to global interventional radiologists and healthcare professionals. The MWA System features precise temperature control, stable microwave energy delivery, and specialized probes for various clinical applications. The company highlighted its commitment to advancing minimally invasive treatments and expanding its global presenc...
09-14 12:00
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan ("DRAP"), further supporting ...
08-20 20:33
Baird Medical announced that its BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from Pakistan's DRAP, supporting its commercial activities in the country. This follows initial approvals and availability at AFIRI in January 2026. Microwave ablation (MWA) is increasingly used for treating benign and malignant soft tissue tumors, offering a minimally invasive option. Baird Medical ...
08-20 12:30
Baird Medical and Alpmed have signed a strategic partnership to develop and commercialize next-generation irreversible electroporation (IRE) technologies globally. Combining Baird's regulatory and commercialization expertise with Alpmed's IRE innovation, the collaboration aims to advance technology development, global approvals, and clinical adoption. The first co-developed product, targeting soft tissue tumors, will seek FDA clearance by late 20...
08-10 12:30